4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001209191-23-017999
Options or other derivatives
- Chief Commercial Officer acquired 80,708 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Mottiwala Aziz · Chief Commercial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-08 | Grant or award : show line 1 in the form Stock Option (right to buy) | +48,116 | 48,116 | D |
| 2023-03-08 | Grant or award : show line 2 in the form Restricted Stock Units | +32,592 | 32,592 | D |
Loading xslF345X03/doc4.xml…